◆ 会议时间：2018年9月6-9日
◆ 会议地点：波兰 波兹南
◆ 下届会议：2019年第31届欧洲超声医学与生物学联合会大会/年会(EUROSON2019/EFSUMB)
◆ 会议简介：
欧洲超声医学与生物学联合会（EFSUMB）成立于1972年，由来自瑞典、比利时、英国、德国、奥地利、法国等13个欧洲国家学会的代表联合发起组建。EFSUMB宗旨是：通过教育、研究、协作促进超声医学与生物学的知识交流与发展；鼓励欧洲各个学科的超声专业人士之间建立联系，从其他国家与其他医疗系统获取知识和经验；举办EUROSON年度会议，提供一个向国际专家学习、交流展示最新数据及研究成果的平台。EFSUMB现由28个欧洲国家学会组成。
Congress EUROSON 2018 will be held simultaneously with the XIV Congress of Polish Scientific Society of Ultrasonography.
The substantive part of the Congress EUROSON 2018 will include the presentation of all the applications of ultrasound in modern diagnostic imaging – on the lectures, plenary sessions and ultrasound training workshops. During the ultrasound apparatus and equipment exhibition, new technologies and programs in sonography will be presented, a rich social part of EUROSON Congress 2018 will enable recreation, socializing and experiencing Polish hospitality.
IMPORTANT DATES：
Online registration from 2.11.2017
Very early bird registration 2.11.2017-1.02.2018
Early bird registration 2.02.2018-1.06.2018
Regular registration 2.06.2018-9.09.2018
Abstract Submission 2.01.2018-15.06.2018
ABSTRACT TOPICS
Topics for Abstract Submission are as below:
Design of clinical trials in the new era,
Personalized cancer medicine,
Immuno-oncology - End Point with Immunotherapy,
Monitoring of Trials and Statistics,
Regulations – Survival based Medicine,
Phase 4 Trials,
Expanded access trials,
Ethics and Patients’ Rights,
Healthcare economy,
End Point with Immunotherapy,
Side Effects.
注册费：
| Type of registration |
Very early bird registration
before or on
February 01, 2018 |
Early bird registration
2.02-01.06.2018 |
Regular registration
2.06-9.09.2018 |
| EFSUMB / PTU Member |
200 € |
300 € |
400 € |
EFSUMB / PTU Member
< 30 y. old |
150 € |
200 € |
300 € |
| Non EFSUMB / PTU Member |
250 € |
350 € |
450 € |
Non EFSUMB / PTU Member
< 30 y. old |
200 € |
250 € |
350 € |
Professiolans in training
(Nurses, Technician,Sonographers) |
200 € |
300 € |
350 € |
| Students |
50 € |
75 € |
100 € |
◆ 参会对象：
政府代表、医院管理者、科室主任、副主任、医生及从相关领域研究的专家、科研人员、医药企业等。
|
